abstract |
The present invention relates to 1- (2- (2-naphthyl) -ethyl) -4- (3-trifluoromethylphenyl) pip eridine and its acid addition salts, useful in the treatment of sexual dysfunction in mammals. The new compound can be prepared for example by catalytic hydrogenation of the corresponding 1,2,3,6 derivative, tetrahydropyridine. |